SCHEMBL845206

SCHEMBL845206

COCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)COC)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 1/20 0.48
PABPC1 P11940 1/20 0.47
TSHR P16473 1/20 0.47
EP300 Q09472 4/20 0.47
CREBBP Q92793 4/20 0.47
KCNH2 Q12809 1/20 0.46
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844900 0.90 CYP2C9 (0.47) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL10119687 0.90 CYP2C9 (0.44) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845478 0.88 NPC1 (0.43) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845486 0.88 MAPK1 (0.50) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845251 0.87 PABPC1 (0.50) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL844966 0.86 VHL (0.44) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL13272504 0.86 VHL (0.44) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845475 0.86 ROCK2 (0.44) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845533 0.86 CYP2C9 (0.46) CYP2C9CYP2C19ALDH1A1MAPK1HTT
SCHEMBL845258 0.85 MAPK1 (0.60) CYP2C9CYP2C19ALDH1A1MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed